Afficher la notice abrégée

A multicenter cross-sectional French study of the impact of COVID-19 on neuromuscular diseases

dc.rights.licenseopenen_US
dc.contributor.authorPISELLA, Lucie Isoline
dc.contributor.authorFERNANDES, Sara
dc.contributor.authorSOLE, Guilhem
dc.contributor.authorSTOJKOVIC, Tanya
dc.contributor.authorTARD, Celine
dc.contributor.authorCHANSON, Jean Baptiste
dc.contributor.authorBOUHOUR, Francoise
dc.contributor.authorSALORT-CAMPANA, Emmanuelle
dc.contributor.authorBEAUDONNET, Guillemette
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorDEBERGE, Louise
dc.contributor.authorDUVAL, Fanny
dc.contributor.authorGRAPPERON, Aude Marie
dc.contributor.authorMASINGUE, Marion
dc.contributor.authorNADAJ-PAKLEZA, Aleksandra
dc.contributor.authorPEREON, Yann
dc.contributor.authorAUDIC, Frederique
dc.contributor.authorBEHIN, Anthony
dc.contributor.authorFRIEDMAN, Diane
dc.contributor.authorMAGOT, Armelle
dc.contributor.authorNOURY, Jean Baptiste
dc.contributor.authorSOUVANNANORATH, Sarah
dc.contributor.authorWAHBI, Karim
dc.contributor.authorANTOINE, Jean Christophe
dc.contributor.authorBIGAUT, Kevin
dc.contributor.authorCAMDESSANCHE, Jean-Philippe
dc.contributor.authorCINTAS, Pascal
dc.contributor.authorDEBS, Rabab
dc.contributor.authorESPIL-TARIS, Caroline
dc.contributor.authorKREMER, Laurent
dc.contributor.authorKUNTZER, Thierry
dc.contributor.authorLAFORET, Pascal
dc.contributor.authorLAUGEL, Vincent
dc.contributor.authorMALLARET, Martial
dc.contributor.authorMICHAUD, Maud
dc.contributor.authorNOLLET, Sylvain
dc.contributor.authorSVAHN, Juliette
dc.contributor.authorVICART, Savine
dc.contributor.authorVILLAR-QUILES, Rocio Nur
dc.contributor.authorDESGUERRE, Isabelle
dc.contributor.authorADAMS, David
dc.contributor.authorSEGOVIA-KUENY, Sandrine
dc.contributor.authorMERRET, Geraldine
dc.contributor.authorHAMMOUDA, Elhadi
dc.contributor.authorMOLON, Annamaria
dc.contributor.authorATTARIAN, Shahram
dc.date.accessioned2021-12-08T14:40:38Z
dc.date.available2021-12-08T14:40:38Z
dc.date.issued2021-10-26
dc.identifier.issn1750-1172 (Electronic) 1750-1172 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/124057
dc.description.abstractEnBACKGROUND: Due to their health condition, patients with neuromuscular diseases (NMD) are at greater risk of developing serious complications with COVID-19. The objective of this study was to analyze the prevalence of COVID-19 among NMD patients and the risk factors for its impact and severity during the first wave of the pandemic. Clinical data were collected from NMD-COVID-19 patients, between March 25, 2020 and May 11, 2020 in an anonymous survey carried out by expert physicians from the French Health Care Network Filnemus. RESULTS: Physicians reported 84 patients, including: 34 with myasthenia gravis, 27 with myopathy and 23 with neuropathy. COVID-19 had no effect on NMD for 48 (58%) patients and 48 (58%) patients developed low COVID-19 severity. COVID-19 caused the death of 9 (11%) NMD patients. Diabetic patients were at greater risk of dying. Patients with diabetes, hypertension or severe forms of NMD had a higher risk of developing a moderate or severe form of COVID-19. In our cohort, corticosteroids and other immunosuppressants were not significantly associated with higher COVID-19 severity for acquired NMD. CONCLUSION: During this period, a small percentage of French NMD patients was affected by COVID-19 compared to the general French population and COVID-19 had a limited short-term effect on them. Diabetes, hypertension and a severe degree of NMD were identified as risk factors of unfavorable outcome following COVID-19. Conversely, in our cohort of patients with acquired NMD, corticosteroids or other immunosuppressants did not appear to be risk factors for more severe COVID-19.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subject.enNeuromuscular diseases
dc.subject.enCOVID-19
dc.subject.enRisk factor
dc.subject.enPrognosis
dc.title.enA multicenter cross-sectional French study of the impact of COVID-19 on neuromuscular diseases
dc.typeArticle de revueen_US
dc.identifier.doi10.1186/s13023-021-02090-yen_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed34702344en_US
bordeaux.journalOrphanet Journal of Rare Diseasesen_US
bordeaux.page450en_US
bordeaux.volume16en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue1en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamHACSen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03470914
hal.version1
hal.date.transferred2021-12-08T14:40:44Z
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Orphanet%20Journal%20of%20Rare%20Diseases&rft.date=2021-10-26&rft.volume=16&rft.issue=1&rft.spage=450&rft.epage=450&rft.eissn=1750-1172%20(Electronic)%201750-1172%20(Linking)&rft.issn=1750-1172%20(Electronic)%201750-1172%20(Linking)&rft.au=PISELLA,%20Lucie%20Isoline&FERNANDES,%20Sara&SOLE,%20Guilhem&STOJKOVIC,%20Tanya&TARD,%20Celine&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Nom:
BPH_OJRD_2021_Pisella.pdf
Taille:
870.6Ko
Format:
PDF
Voir/Ouvrir
Thumbnail
Nom:
license_rdf
Taille:
914octets
Format:
application/rdf+xml
Voir/Ouvrir

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée